<!DOCTYPE html >
<html id="aqmQN30oURlGj0j2zX21_jKCkNkG-18305173" data-origid="18305173" class="anndoc" data-anndoc-version="2.0" lang="" xml:lang="" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <meta charset="UTF-8"/>
    <meta name="generator" content="net.tagtog.anndoc.v2.parsers.bio.PubMedAbstractsParser_v0_1$"/>
    <meta name="dcterms.source" content="http://www.ncbi.nlm.nih.gov/pubmed/18305173"/>
    <title>aqmQN30oURlGj0j2zX21_jKCkNkG-18305173</title>
  </head>
  <body>
    <article>
      <section data-type="title">
        <h2 id="s1h1">MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation.</h2>
      </section>
      <section data-type="abstract">
        <h2 id="s2h1">Abstract</h2>
        <div class="content">
          <p id="s2p1">In response to Toll-like receptor ligands, dendritic cells (DCs) dramatically enhance their antigen presentation capacity by stabilizing at the cell-surface MHC II molecules. We demonstrate here that, in human monocyte-derived DCs, the RING-CH ubiquitin E3 ligase, membrane-associated RING-CH I (MARCH I), promotes the ubiquitination of the HLA-DR beta-chain. Thus, in nonactivated DCs, MARCH I induces the surface internalization of mature HLA-DR complexes, therefore reducing their stability and levels. We further demonstrate that the maturation-dependent down-regulation of MARCH I is a key event in MHC class II up-regulation at the surface of LPS-activated DCs. MARCH I is, therefore, a major regulator of HLA-DR traffic, and its loss contributes to the acquisition of the potent immunostimulatory properties of mature human DCs.</p>
        </div>
      </section>
    </article>
  </body>
</html>
